Form D · Pharmaceuticals

AXIKIN PHARMACEUTICALS INC

San Diego, CA · CIK 0001439059

Offering snapshot reported Sep 28, 2015 · SEC filing

Reported sold
$6.5M
Offering amount: $11.6M
Investors reported
7
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 12, 2014
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$3.25M$6.5MMar 27, 2014: $6,000,000.00Mar 27, 2014Sep 28, 2015: $6,500,000.00Sep 28, 2015

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$6,000,000 → $6,500,000
  • Reported investors2 → 7

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 28, 2015Amendment$6,500,000$500,000vs Mar 27, 20147SEC filing
Mar 27, 2014Initial$6,000,000No comparison2SEC filing
Mar 29, 2012Initial$2,000,000No comparison2SEC filing
Aug 12, 2010Initial$1,000,000No comparison4SEC filing
Jun 30, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-214321
This filing includes amounts receivable by the Company upon the exercise of Warrants to purchase shares of the Company's Common Stock, assuming no cashless exercise. Such Warrants have not yet been exercised.

Source: Form D, filed Sep 28, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Kevin B. Bacon Director, Executive
Dan Liu Director
Masaji Matsuoka Director
Peter C.M. Mc Williams Director, Executive
Fred A. Middleton Director
Walter Olesiak Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
10835 Road To The Cure Suite 250
San Diego, CA, 92121